Back to results
US 2026/0251663 A1Published application
Methods for distinguishing lung cancer from non-cancer
AssigneePrognomIQ, Inc.
InventorsBruce WILCOX, Manway LIU, Brian D. KOH, Philip MA, Vernon NORVIEL
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of detecting lung cancer associated markers in a biological sample and for using one or more lung cancer associated markers to assess lung cancer in a biological sample. Also provided herein are systems, compositions, and kits for performing the methods disclosed herein.
Claims32
A method for detecting lung cancer associated proteomic markers, the method comprising:
- (a) creating a dataset comprising a plurality of lung cancer associated proteomic markers from lung cancer samples and non-cancer samples, wherein the lung cancer samples are no more than 20% of samples used to create the dataset;
- (b) training a classifier with the dataset in (a) to generate a trained classifier, wherein the trained classifier distinguishes lung cancer samples from non-cancer samples;
- (c) obtaining a biofluid sample from a subject;
- (d) measuring an amount or a concentration of the lung cancer associated proteomic markers in the biofluid sample or a processed sample therefrom to obtain proteomic measurements;
- and
- (e) applying the trained classifier to the proteomic measurements to provide a quantitative or qualitative result for the biofluid sample of the lung cancer.
3 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.